Suchergebnisse - "Kayser, Sabine"

PubPharm (127)

41

Two rare cases of bronchus-associated lymphoid tissue lymphoma successfully treated with rituximab-bendamustine

enthalten in: Clinical case reports | 2021

von Panitz, N. | Gerhardt, K. | Becker, C. | +6

42

Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Wang, S. | Thomassen, K. | Kurch, L. | +5

43

Rationale and Design of GnG-Trial: A Randomized Phase-III Study to Compare Two Schedules of Gemtuzumab Ozogamicin as Adjunct to Intensive Induction Therapy and to Compare Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Older Patients with Newly Diagnosed AML

enthalten in: ResearchSquare.com | 2021

von Jaramillo, S. | Krisam, J. | Cornet, L. | +32

44

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13) : results from an International Collaborative Study

enthalten in: British journal of haematology | 2021

von Kayser, S. | Hills, R. | Langova, R. | +28

CommentIn: Br J Haematol. 2021 Mar;192(5):800-802. - PMID 33540474

45

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma : Case Report

enthalten in: Frontiers in oncology | 2021

von Kurch, L. | Georgi, T. | Monecke, A. | +8

46

Rationale and design of the 2 by 2 factorial design GnG-trial : a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML

enthalten in: Trials | 03 November 2021

von Jaramillo Segura, S. | Krisam, J. | Le Cornet, L. | +32

47

Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13) : results from an International Collaborative Study*

enthalten in: British Journal of Haematology | 2021

von Kayser, S. | Hills, R. | Langova, R. | +28

48

Two rare cases of bronchus‐associated lymphoid tissue lymphoma successfully treated with rituximab‐bendamustine

enthalten in: Clinical Case Reports | 2021

von Panitz, N. | Gerhardt, K. | Becker, C. | +6

49

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

enthalten in: Leukemia | 2020

von Kayser, S. | Rahmé, R. | Martínez-Cuadrón, D. | +20

ErratumIn: Leukemia. 2021 Dec;35(12):3631. - PMID 34785795

50

A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia

enthalten in: Blood advances | 2020

von Smith, C. | Levis, M. | Frankfurt, O. | +13